Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Operating Expenses (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Operating Expenses for 16 consecutive years, with $3.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses fell 7.05% year-over-year to $3.3 million, compared with a TTM value of $13.6 million through Sep 2025, down 0.68%, and an annual FY2024 reading of $14.1 million, up 6.63% over the prior year.
  • Operating Expenses was $3.3 million for Q3 2025 at Rockwell Medical, up from $3.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $6.1 million in Q2 2021 and bottomed at $2.9 million in Q4 2023.
  • Average Operating Expenses over 5 years is $4.1 million, with a median of $3.7 million recorded in 2025.
  • The sharpest move saw Operating Expenses soared 35.81% in 2021, then plummeted 39.27% in 2023.
  • Year by year, Operating Expenses stood at $5.3 million in 2021, then decreased by 25.1% to $3.9 million in 2022, then fell by 26.93% to $2.9 million in 2023, then grew by 14.99% to $3.3 million in 2024, then grew by 0.54% to $3.3 million in 2025.
  • Business Quant data shows Operating Expenses for RMTI at $3.3 million in Q3 2025, $3.3 million in Q2 2025, and $3.7 million in Q1 2025.